PPIB and hepatitis A virus infection: Oral acyclovir - 400 mg BID (HSV); 800mg BID (HZV) ororal valacyclovir - 500 mg BIDTenofovir or entecavir (instead of lamivudine) in patients at intermediate or high risk of hepatitis B reactivation.